Searched for
CARDIOVASCULAR STENTS
Think chest pain is the only sign of heart attack? Top doctor breaks 10 myths about the medical condition most people get wrongHeart attacks are often misunderstood. Warning signs can appear days or weeks before. Many people believe dangerous myths about symptoms, r...- H&F weighs $9 billion-plus sale of medical device maker Cordis: ReportU.S. private equity firm Hellman & Friedman is exploring a sale of medical devices maker Cordis, aiming for a valuation exceeding $9 billio...
- 35 per cent of women die from heart attacks globally; know more about red flags & post-surgery careWorldwide, many women are succumbing to heart attacks.
- Delhi High Court seeks Centre's stand on plea on sale of coronary stentsThe petitioner, an advocate, said in his plea that currently cardiac stents are allowed to be manufactured, imported and sold "without or w...
- Cap on trade margin of 42 non-scheduled cancer drugs by NPPA led to up to 90 pc reduction in MRP: Mansukh Mandaviya"The total annual savings on account of revision of ceiling prices of medicines under the National List of Essential Medicines (NLEM), pric...
- Number of cath-labs in country up 100% in 5 yearsAnalysis of the NSSO 71st round done in the paper also show that one-fifth of hospitalisations due to CVD were paid for by borrowings or sa...
- Everstone picks up minority stake in stent company TransluminaDeal worth Rs 500 crore to help Indian stent maker acquire global assets, boost R&D efforts
- Hopeful of settlement between India and US over GSP conflict: AdvamedIn 2017 India was the biggest beneficiary of GSP with a subsidies worth $5.6 billion.
- Indian-American invest $60 million in medical device companyDr Kiran Patel's investment is for the Concept Medical Inc, a Florida-based medical device company's Investigational Device Exemption (IDE)...
- Prices of 869 formulations to go up by 3.44%: NPPAThe development follows a price revision as per annual Wholesale Price Index (WPI) at the rate of 3.44 percent increase, the National Pharm...
- Stent prices under the cosh again, but who will bell the real cat?The decision is a blow for stent makers, who have been clamouring for higher prices and a system to rationalise margins instead of blanket ...
- Surgical strike! Prices of drug eluting stents cutCoronary stents are wire mesh tubes inserted into coronary arteries to clear blockages and prevent heart attacks.
- Drug eluting stents expected to get cheaperThe maximum price that patients should pay for drug eluting, bioresorbable vascular and biodegradable coronary stents was reduced to Rs 27,...
- Domestic stent manufacturer SMT raises Rs 250 crore from Morgan Stanley PE & Samara CapitalThe proceeds from the transaction will be used to finance SMT’s strong organic growth, achieve synergistic acquisitions and build an aggres...
- Samara Capital buys stake in SMTAs part of the deal, Samara Capital's managing director Gautam Gode and vice president Abhishek Kabra will come on SMT's board.
- Government in talks with manufacturers to lower prices of stentsThe government is discussing the issue of "voluntary" reduction of price of stents with leading manufacturers, Lok Sabha was informed today.
- Central government hospitals to offer cancer drugs, stents at 60% discount soonThe government will run pharmacy retail stores to sell medicines in hospitals like AIIMS, Safdarjung Hospital and Ram Manohar Lohia Hospita...
- Indian study on treating diabetics with heart ailments gets global recognitionAs per the findings, the use of Everolimus eluting stents may be equally or more useful in treating coronary blockages in diabetic patients...
- Patients spend Rs 2,500 crore on stents every year in IndiaAdd the numbers up and the total spending on stents of all kinds would be at least Rs 2,500 crore.
- Cost effect: Stents costing Rs 40,000 sold to you at Rs 1.2 lakhThe dealer price or the landed cost in India for a drug eluting stent (DES) is not more than Rs 40,000, often just Rs 20,000.
Load More
